White Pine Capital LLC Lowers Stake in Electromed, Inc. (NYSE:ELMD)

White Pine Capital LLC lessened its holdings in shares of Electromed, Inc. (NYSE:ELMD) by 2.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,615 shares of the company’s stock after selling 828 shares during the quarter. White Pine Capital LLC owned about 0.37% of Electromed worth $934,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently added to or reduced their stakes in ELMD. Legacy Wealth Asset Management LLC acquired a new stake in shares of Electromed during the fourth quarter worth about $253,000. Barclays PLC purchased a new position in Electromed during the third quarter worth about $215,000. Wilmington Savings Fund Society FSB acquired a new stake in Electromed in the third quarter valued at about $226,000. Walleye Capital LLC acquired a new stake in Electromed in the third quarter valued at about $274,000. Finally, Ritholtz Wealth Management purchased a new stake in Electromed in the 4th quarter valued at approximately $488,000. 40.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com raised Electromed from a “buy” rating to a “strong-buy” rating in a report on Tuesday.

Insider Buying and Selling

In other Electromed news, Director Andrew Summers sold 12,731 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the completion of the transaction, the director now directly owns 165,755 shares in the company, valued at approximately $4,969,334.90. This trade represents a 7.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 14.00% of the stock is currently owned by insiders.

Electromed Stock Down 0.2 %

Shares of NYSE ELMD opened at $33.21 on Friday. The stock has a market capitalization of $280.96 million, a price-to-earnings ratio of 46.13 and a beta of 0.33. Electromed, Inc. has a 52 week low of $11.15 and a 52 week high of $35.56. The firm has a 50-day moving average price of $31.18 and a 200 day moving average price of $24.61.

Electromed (NYSE:ELMD) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million during the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.